期刊文献+

转化生长因子-β1及p21对乳腺癌干细胞的作用 被引量:5

The research of the transforming growth factor β1 and p21 effect on breast cancer stem cells
原文传递
导出
摘要 目的观察转化生长因子-β1(TGF-β1)诱导乳腺癌耐阿霉素细胞株MCFT/ADM中乳腺癌干细胞富集的作用,比较乳腺癌干细胞和MCF7/ADM中p21基因和蛋白水平的表达差异。方法流式细胞仪检测阿霉素耐药乳腺癌细胞(ADM细胞)、乳腺细胞球培养法富集的乳腺癌细胞(sc细胞)及加入TGF-β1细胞因子诱导的乳腺癌细胞(sc—T细胞)中乙醛脱氢酶1(ALDH1)阳性细胞比例;比较上述3组细胞微球形成能力差异;逆转录-聚合酶链反应(RT—PCR)及Westernblot检测3组细胞中p21基因及蛋白水平的表达差异。结果ADM组、SC组及Sc—T组中ALDH1阳性细胞比例分别为8.49%、14.94%及23.44%;细胞微球形成率分别为5.29%、11.67%、23.13%;3组细胞中p21mRNA及蛋白水平的表达均逐渐升高。结论TGF-β1能诱导乳腺癌干细胞的富集并使其具有更强的自我更新能力。P21在乳腺癌干细胞中高表达。 Objective To detect the enrichment of breast cancer stem cells induced by transfor- ming growth factor 131 (TGF-β1) , and the difference of p21 expression between breast cancer stem cells and MCFT/ADM cells. Methods Flow cytometry detect the proportion of aldehyde dehydrogenase 1 (ALDH1) positive cells in MCF7/ADM, breast cancer stem cells enriched by mammosphere and breast cancer stem cells induced by TGF-β1. To detect the mammoshpere formation ability in above three teams by mammoshpere formation test. To detect the p21 expression in three teams above by reverse transcription- polymerase chain reaction (RT-PCR) and Western blotting. Results The proportion of ALDH1 positive cells in the three teams were 8.49% , 14. 94% , 23.44% respectively. The mammosphere formation rate were 5.29% , 11.67%, 23. 13% respectively. The expression of p21 increased in the three teams. Conclusion TGF-β1 can induce the enrichment of breast cancer stem cells, and enhance it' s self-renewal ability. The expression of p21 is higher in breast cancer stem cells than common breast cancer cells.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第5期815-817,共3页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30801116/H1622)
关键词 乳腺癌干细胞 转化生长因子-Β1 乙醛脱氢酶1 P21 Breast cancer stem cell Transforming growth factor-β1 Aldehyde dehydrogenase 1 p21
  • 相关文献

参考文献14

  • 1Asiedu MK, Ingle JN, Behrens MD, et al. TGFbeta/TNF (alpha) -mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin.olow phenotype. Cancer Res, 2011,71 : 4707- 4719.
  • 2Stier S, Cheng T, Forkert R, et al. Ex vivo targeting of p21^cipt/wafl permits relative expansion of human hematopoictie stern cells. Blood, 2003,102 : 1260-1266.
  • 3van Os R, 'Kanurtinga LM,Ausema A,et al. A Limited role for p21^cipt/wafl in maintaining normal hematopoietic stern cell functioning. Stem Cells, 2007,25 : 836-843.
  • 4Yu H, Yuan Y, Shen H, et al. Hematopoietlc stem cell exhaustion impacted by p18 INK4C and p21^cipt/wafl in opposite manners. Blood, 2006,107 : 1200-1206.
  • 5Zhang J, Attar E, Cohen K, et al. Silencing p21^(Wafl/Ctp1/Sdil) expression increases gene transduction efficiency in primitive human hematopoietic ceils. Gene Ther,2005,12:1444-1452.
  • 6Liu M, Casimiro MC, Wang C, et al. p21^CIP1 attenuates Ras-and cMyc-dependent breast tumor epithelial mesenehymal transition and cancer stem cell-like gene expression in vivo. Proc Natl Acad Sci U S A, 2009,106 : 19035-19039.
  • 7Al-Hajj M,Wieha MS, Benito-Hemandez A, et al. Prospective identification of tumorigenic breast cancer eells. Proc Natl Acad Sci U S A, 2003,100:3983-3988.
  • 8Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDHI is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell ,2007,1:555-567.
  • 9Ponti D, Costa A, Zaithroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer ceils with stem/progenltor cell properties. Cancer Res,2005,65:5506-5511.
  • 10Kok M, Koornstra RH, Margarido TC, et al. Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer. J Patho1,2009 ,218 :316-326.

二级参考文献8

  • 1陈剑英,张波,王国斌,郑海,陈庆勇,陈道达.人类乳腺癌基因表达分析[J].中华实验外科杂志,2005,22(4):429-431. 被引量:15
  • 2廖松林,现代诊断病理学手册,1995年,387页
  • 3Li K,Lin SY,Brunicardi FC,et al.Use of RNA interference to target Cyclin E overexpressing hepatocellular carcinoma.Cancer Res,2003,63:3593-3597.
  • 4Dimri GP,Xinhua L,Basile G,et al.A biomarker that identifies senescent human cells in cultureand in aging skin in vivo.Proc Natl Acad Sci USA,1995,92:9363-9367.
  • 5Hunt KK,Keyomarsi K.Cyclin E as a prognostic and predictive marker in breast cancer.Semi Cancer Biol,2005,15:319-326.
  • 6Campisi J.Cellular senescence as a tumor-suppressor mechanism.Trends Cell Biol,2001,11:27-31.
  • 7Te Poele RH,Okorokov AL,JardineL,et al.DNA damage is able to induce senescence in tumor cells in vitro and in vivo.Cancer Res,2002,62:1876-1883.
  • 8张波,陈道达,王国斌,吴毅华.雌二醇、三苯氧胺对乳腺癌和子宫内膜细胞增殖的影响[J].中华实验外科杂志,2002,19(2):139-140. 被引量:3

共引文献13

同被引文献35

  • 1翟荣林,王国斌,夏泽峰.c-myc靶向小干扰RNA诱导乳腺癌细胞凋亡的作用[J].中华实验外科杂志,2005,22(6):698-700. 被引量:21
  • 2唐峰,顾栋桦,王虹,朱腾芳,朱虹光,许组德,胡锡琪.端粒酶hTERT mRNA表达在乳腺癌进展中的意义及其与p53的相关性[J].中华肿瘤杂志,2006,28(3):192-195. 被引量:13
  • 3Miyazaki Y, Shibuya M, Sugawara H, et al.Salinomycin, a new polyether antibiotic. J Antibiot ( Tokyo), 1974,27:814-821.
  • 4Gupta PB, Onder TY, Jiang G, et al. Identi- fication of selective inhibitors of cancer stem cells by high-throughput screening. Cell ,2009,138:645-659.
  • 5Ponti D, Costa A, Zaffaroni N, et al. Isola- tion and in vitro propagation of tumorigenic breast cancer ceils with stem/progenitor cell properties. Cancer Res, 2005, 65: 5506-5511.
  • 6Dontu G, Abdallah WM, Foley JM, et al. Invitro propagation and transcriptional profi- ling of human mammary stem/progenitor cells. Genes Dev,2003,17 : 1253-1270.
  • 7Ginestier C, Hur MH, Charafe-,lauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Ce11,2007,1:555-567.
  • 8Al-Ejeh F,Smart CE,Morrison BJ,et al.Breast cancer stem cells :treatment resistance and therapeutic opportunities [J].Carcinogene- sis,2011 ,32(5):650-8.
  • 9Oliveras-Ferraros C,Vazquez-Martin A,Martin-CastilIo B,et al.Dy- namic emergence of the mesenchymal CD44( pos ) CD24( neg/low ) phenotype in HER2-gene amplifed breast cancer cells with de novo re- sistance to trastuzumab ( Herceptin)[J].Biochem Biophys Res Com- mun,2010,397( 1 ):27-33.
  • 10Hirsch HA,Iliopoulos D,Tsichlis PN,et al.Metformin selectively tar- gets cancer stem cells,and acts together with chemotherapy to block tumor growth and prolong remission [J].Cancer Res,2009,69(19):7507-7511.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部